We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.

Close

SHARES NEWS & ANALYSIS

Your filtered view of the latest news and analysis

  • Wilmington knows the way

    27 February 2015

    Wilmington delivered broad first-half gains, partly offset by pernicious legal regulations
  • Asian Citrus battered by the weather

    27 February 2015

    Asian Citrus had a terrible first half and trading doesn't look set to get juicier any time soon.
  • MJ Gleeson order book grows Tip Update

    26 February 2015

    The demand for low-cost housing in the north of England is great news for MJ Gleeson, whatever the outcome of the election
  • Orders up at Kier

    26 February 2015

    Construction giant Kier is benefiting from strong housing demand
  • Barratt plotting higher margins

    25 February 2015

    Barratt Developments has benefited from the recovering housing market as well as its continued investment in new land
  • dotDigital crosses all channels

    25 February 2015

    dotDigital's new chief has unveiled plans to tap into the enormous US and Asia Pacific markets
  • Regional boost for Town Centre Securities Tip Update

    25 February 2015

    Demand for quality retail space is finally spreading beyond London
  • Green REIT gathers momentum

    24 February 2015

    Demand for prime space in Dublin is growing strongly, but supply remains tight
  • Defined-benefit gain for Just Retirement

    24 February 2015

    Individual annuity sales fell sharply, but the defined-benefit business is taking off.
  • Russian trouble for Genus

    24 February 2015

    Genetics specialist Genus insists its full-year performance won't be hurt by turbulence in Russia
  • Ashmore sees asset decline

    24 February 2015

    Ashmore had to meet $9.8bn in first-half redemptions as sentiment towards emerging markets remained negative during the last six months of 2014
  • Dechra beats the currency crunch

    24 February 2015

    Dechra Pharmaceuticals enjoyed a strong six months despite strong currency headwinds and curbs on antibiotic prescriptions in Europe.

Register today and get...

Register today and get...
Please note terms & conditions apply